Safety profile and clinical activity of sifalimumab, a fully human anti-interferon monoclonal antibody, in systemic lupus erythematosus: a phase I, multicentre, double-blind randomised study

Published 2011 View Full Article

Authors

Keywords

Journal

ANNALS OF THE RHEUMATIC DISEASES

Volume 70, Issue 11, Pages 1905-1913

Publisher

BMJ

Online

2011-07-29

DOI

10.1136/ard.2010.144485

Ask authors/readers for more resources

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started

ANNALS OF THE RHEUMATIC DISEASES

Ask authors/readers for more resources

Protocol

Reagent

Reprint

Find the ideal target journal for your manuscript

Become a Peeref-certified reviewer